Thus, immunohistochemical co-expression of β-Cat, GS, and GPC3 observed in HCC suggests that GPC3-induced activation of the Wnt/β-Cat pathway is responsible for the development of malignant hepatocellular tumors [5]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.